Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Ritlecitinib 100 mg's trials
ALLEGRO-100
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Ritlecitinib 100 mg
Ongoing
Recruiting
Phase 3
Open NCT06873945 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
